TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
11,524
|
11,025
|
11,648 |
| Financial expenses |
109
|
183
|
162 |
| Earnings before taxes |
-639
|
-3,670
|
-2,274 |
| EBITDA |
825
|
-2,443
|
-1,299 |
| Total assets |
14,693
|
14,720
|
18,700 |
| Current assets |
7,268
|
6,244
|
6,381 |
| Current liabilities |
3,340
|
7,237
|
6,394 |
| Equity capital |
10,822
|
6,801
|
12,158 |
| - share capital |
13
|
14
|
13 |
| Employees (average) |
53
|
69
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
73.7%
|
46.2%
|
65.0% |
| Turnover per employee |
217
|
160
|
155 |
| Profit as a percentage of turnover |
-5.5%
|
-33.3%
|
-19.5% |
| Return on assets (ROA) |
-3.6%
|
-23.7%
|
-11.3% |
| Current ratio |
217.6%
|
86.3%
|
99.8% |
| Return on equity (ROE) |
-5.9%
|
-54.0%
|
-18.7% |
| Change turnover |
873
|
-657
|
-100 |
| Change turnover % |
8%
|
-6% | |
| Chg. No. of employees |
-16
|
-6
|
9 |
| Chg. No. of employees % |
-23%
|
-8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.